These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3814682

  • 21. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression.
    Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK.
    Biol Psychiatry; 1987 Feb; 22(2):228-34. PubMed ID: 3028512
    [No Abstract] [Full Text] [Related]

  • 22. Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol.
    Halbreich U, Naor S, Asnis G, Gasparini F, Goldstein S, Vital-Herne J, Kang BJ.
    Biol Psychiatry; 1986 Dec; 21(14):1434-7. PubMed ID: 3790627
    [No Abstract] [Full Text] [Related]

  • 23. The influence of weight loss on the dexamethasone suppression test.
    Yerevanian BI, Baciewicz GJ, Iker HP, Privitera MR.
    Psychiatry Res; 1984 Jun; 12(2):155-60. PubMed ID: 6591220
    [Abstract] [Full Text] [Related]

  • 24. Age and gender effects on the diagnostic power of the DST.
    Ansseau M, Depauw Y, Charles G, Castro P, D'Haenen H, De Vigne JP, Hubain P, Legros JJ, Pelc I, Toscano A.
    J Affect Disord; 1987 Jun; 12(3):185-91. PubMed ID: 2956303
    [Abstract] [Full Text] [Related]

  • 25. Neuroendocrine interrelationships in major depressive disorder.
    Targum SD, Sullivan AC, Byrnes SM.
    Am J Psychiatry; 1982 Mar; 139(3):282-6. PubMed ID: 6800269
    [Abstract] [Full Text] [Related]

  • 26. Adrenocorticotropin and cortisol response to lysine vasopressin in relation to the outcome of the dexamethasone suppression test in major depressive disorder.
    Akner G, Ljunggren JG, Kjellman BF, Undén F, Wetterberg L.
    Acta Psychiatr Scand; 1988 Apr; 77(4):404-10. PubMed ID: 2839010
    [Abstract] [Full Text] [Related]

  • 27. Multiple depressive episodes and plasma postdexamethasone cortisol levels.
    Meador-Woodruff JH, Gurguis G, Grunhaus L, Haskett RF, Greden JF.
    Biol Psychiatry; 1987 May; 22(5):583-92. PubMed ID: 3580433
    [Abstract] [Full Text] [Related]

  • 28. Similarities in hypothalamic-pituitary-adrenal axis activity between patients with panic disorder and those experiencing external stress.
    Kathol RG, Noyes R, Lopez A.
    Psychiatr Clin North Am; 1988 Jun; 11(2):335-48. PubMed ID: 3047703
    [Abstract] [Full Text] [Related]

  • 29. The dexamethasone suppression test in depressed retarded adults: preliminary findings.
    Beckwith BE, Parker L, Pawlarczyk D, Couk DI, Schumacher KS, Yearwood K.
    Biol Psychiatry; 1985 Aug; 20(8):825-31. PubMed ID: 4027299
    [Abstract] [Full Text] [Related]

  • 30. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW.
    Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
    [Abstract] [Full Text] [Related]

  • 31. HPA axis disturbance and treatment outcome in panic disorder.
    Coryell W, Noyes R.
    Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754
    [Abstract] [Full Text] [Related]

  • 32. Occurrence of high concentrations of postdexamethasone cortisol in elderly psychiatric inpatients.
    Fogel BS, Satel SL, Levy S.
    Psychiatry Res; 1985 Jun; 15(2):85-90. PubMed ID: 3862149
    [Abstract] [Full Text] [Related]

  • 33. [Dexamethasone suppression test repeated after a suicide attempt].
    Wilmotte J, Van Wettere JP, Depauw Y, Charles G.
    Acta Psychiatr Belg; 1986 Jun; 86(3):242-8. PubMed ID: 3751647
    [Abstract] [Full Text] [Related]

  • 34. Comparative dexamethasone suppression test measurements in bulimia, depression and normal controls.
    Musisi S, Garfinkel P.
    Can J Psychiatry; 1985 Apr; 30(3):190-4. PubMed ID: 3857956
    [Abstract] [Full Text] [Related]

  • 35. Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology.
    Gerken A, Maier W, Holsboer F.
    Psychoneuroendocrinology; 1985 Apr; 10(3):261-71. PubMed ID: 4059474
    [Abstract] [Full Text] [Related]

  • 36. [Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis findings in depressive disorder].
    Sarandöl A, Taneli B, Sivrioğlu Y.
    Turk Psikiyatri Derg; 2003 Apr; 14(2):116-24. PubMed ID: 12844278
    [Abstract] [Full Text] [Related]

  • 37. Memory disturbances and dexamethasone suppression test in major depression.
    Wauthy J, Ansseau M, von Frenckell R, Mormont C, Legros JJ.
    Biol Psychiatry; 1991 Oct 01; 30(7):736-8. PubMed ID: 1958771
    [No Abstract] [Full Text] [Related]

  • 38. Repeated dexamethasone suppression test in depressed patients.
    Maes M, De Ruyter M, Hobin P, Suy E.
    J Affect Disord; 1986 Oct 01; 11(2):165-72. PubMed ID: 2948992
    [Abstract] [Full Text] [Related]

  • 39. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB, Weller RA, Fristad MA, Preskorn SH, Teare M.
    J Clin Psychiatry; 1985 Dec 01; 46(12):511-3. PubMed ID: 4066616
    [Abstract] [Full Text] [Related]

  • 40. Cortisol stress response in post-traumatic stress disorder, panic disorder, and major depressive disorder patients.
    Wichmann S, Kirschbaum C, Böhme C, Petrowski K.
    Psychoneuroendocrinology; 2017 Sep 01; 83():135-141. PubMed ID: 28623762
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.